Advancing Novel Medical Isotopes for Clinical Trials
The summary for the Advancing Novel Medical Isotopes for Clinical Trials grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Office of Science, which is the U.S. government agency offering this grant.
Advancing Novel Medical Isotopes for Clinical Trials: The DOE SC program in Isotope R&D and Production (DOE IP) hereby announces its interest in receiving applications for research to facilitate, streamline, and accelerate the translation of novel radioisotopes and their associated chelating agents and linker/ligands, for both diagnosis and treatment, from the laboratory bench to evaluation for potential usage in clinical and pre-clinical trials. Evaluating these materials for use in clinical and pre-clinical trials is beyond the scope of this FOA as well as outside the mission of the DOE IP: Applications requesting support for such evaluations will be declined without merit review. Successful applications would benefit the public by leveraging the scientific and technical capabilities of existing facilities at institutions of higher education, non-profit research institutions, and DOE/National Nuclear Security Administration (NNSA) National Laboratories to accelerate the development process for new diagnostic and therapeutic agents. Applications focused on aspects of isotope R&D not associated with translational research are outside the scope of this FOA and will be declined without merit review. Applications are restricted to recently-developed medical isotopes by the DOE IP (listed on the next page) but are not restricted in chelator/ligand technology. Applications incorporating effective ways to train personnel with essential knowledge and skills related to the production, processing, purification, and distribution of enriched stable and radioactive isotopes are strongly encouraged. While this FOA is administered by the DOE IP, the assessment of submitted proposals will be in coordination with the National Institutes of Health.
Federal Grant Title: | Advancing Novel Medical Isotopes for Clinical Trials |
Federal Agency Name: | Office of Science (PAMS-SC) |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | DE-FOA-0002532 |
Type of Funding: | Grant |
CFDA Numbers: | 81.049 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | July 23rd, 2021 |
Original Application Deadline: | July 23rd, 2021 |
Posted Date: | June 1st, 2021 |
Creation Date: | June 1st, 2021 |
Archive Date: | August 22nd, 2021 |
Total Program Funding: | |
Maximum Federal Grant Award: | $500,000 |
Minimum Federal Grant Award: | $100,000 |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | June 1st, 2021 |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Refer to page 9 of the FOA.
- Grant Announcement Contact
- Ethan Balkin, Ph.D.
Program Manger
Phone 301-903-1861
[email protected] - Similar Government Grants
- • Quantum Information Science Enabled Discovery (QuantISED 2.0)
- • FY 2024 Funding for Accelerated, Inclusive Research (FAIR)
- • FY 2024 Reaching a New Energy Sciences Workforce (RENEW)
- • FY 2024 Phase II Release 2
- • Research on General Plasma Science Collaborative Research Facilities
- • Atmospheric Radiation Measurement Program
- • Integrated Assessment of Climate Change Research
- • Research in Innovative Approaches to Fusion Energy Sciences
- More Grants from the Office of Science
- • Quantum Information Science Enabled Discovery (QuantISED 2.0)
- • FY 2024 Funding for Accelerated, Inclusive Research (FAIR)
- • FY 2024 Reaching a New Energy Sciences Workforce (RENEW)